Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Stakeholders Oppose Proposal To Cut IVIG Preadministration Fee In Medicare

Executive Summary

Industry groups are asking CMS to back off on a proposal to cut the $37 preadministration fee for intravenous immune globulin therapies administered in the hospital outpatient setting
Advertisement

Related Content

Plasma Group To Seek Legislation On IVIG Access As CMS Cuts Preadmin Fee
Plasma Group To Seek Legislation On IVIG Access As CMS Cuts Preadmin Fee
Increase In Pay For Part B Hospital Outpatient Drugs Needed, Groups Tell CMS
CMS Proposes Dropping IVIG Preadministration Fee In 2009
CMS Proposes Dropping IVIG Preadministration Fee In 2009
Advertisement
UsernamePublicRestriction

Register

PS050158

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel